Abiogenesis Clinpharm Private Limited - Company overview

Registered with ROC Hyderabad on 21 November 2014, Abiogenesis Clinpharm is an active private limited company that has been around for about…

2014-11-21 Hyderabad, Telangana Active Unlisted Active Compliant
Connect MCP

Key Metrics Public MCA facts are exact. Revenue, profit, assets, and employee figures may show as ranges until unlocked.

REVENUE
₹5–10 Cr
▲ 195.0%
FY 2020
PROFIT / LOSS
₹50 Lakh–1 Cr
▲ 319.6%
FY 2020
EBITDA
₹50 Lakh–1 Cr
▲ 526.8%
FY 2020
NET WORTH
₹50 Lakh–1 Cr
▲ 163.0%
FY 2020
TOTAL ASSETS
₹1–5 Cr
▲ 208.2%
FY 2020
EMPLOYEE COUNT
21–30
OPEN CHARGES
2
-
PAID-UP CAPITAL
1.25 cr
AUTHORISED CAPITAL
1.25 cr
COMPANY AGE
11 Years 11 Months
since 2014-11-21
LAST FILING WITH ROC
2025-03-31
Last AGM: 2025-09-30
ACTIVE GST
1
Updated: 2023-02-24 08:54:26
SATISFIED CHARGES
-
-

Company Health Scores Scores from 0–100 based on filings, compliance signals, financials, and board history on this profile.

Health scores for Abiogenesis Clinpharm covering vendor trust, statutory compliance, financial health and director risk - derived from MCA filings, GST and EPFO records, financial statements and the company's board history.

Vendor Trust Score Low risk
93/100
Overall counterparty comfort for vendors and customers.
  • Blend of compliance (88), financial health (95), director (95) and company-foundation signals.
  • Operating for 11+ years.
Compliance Score Low risk
88/100
Statutory filings, status and regulatory flags.
  • Company status is Active as per MCA.
  • Last balance sheet filed for Mar 2025 - slightly behind.
Financial Health Score Low risk
95/100
Profitability, leverage and liquidity from filed statements.
  • Profitable in FY 2020.
  • Positive net worth.
Director Risk Score Low risk
95/100
Board strength, DIN status and churn.
  • 3 directors on the board.
  • No disqualified or deactivated DINs on the current board.
Scores are derived from MCA filings, financial statements and public records on this page. Higher is safer. They are indicative, not a credit rating.
360° Intelligence Report: trust score, financial health, credit risk, growth & distress signals - auto-generated from filings. View report →

About Abiogenesis Clinpharm Company identity, industry, contact, and registration details from MCA and company records.

Registered with ROC Hyderabad on 21 November 2014, Abiogenesis Clinpharm is an active private limited company that has been around for about 11 years. The registered office is at Plot No 69, 8-2-248/1/7/69 Nagarjuna Hills, Punjagutta, Hyderabad, Telangana.

In its MCA filings the main business is listed as other professional, scientific and technical activities, which made up 100% of turnover.

It has three directors: Abraham Chikku Joseph, Pawan Ishwarrao Bhusari and Kalpesh Kumar Prabhudas Saglani. The longest-serving is Pawan Ishwarrao Bhusari, on the board since 2014; the most recent to join is Kalpesh Kumar Prabhudas Saglani, appointed in November 2025. One former director, Snehal Bhusari, left in July 2019.

Authorised and paid-up capital are both ₹1.25 crore, so the full authorised amount has been issued. Its latest balance sheet on MCA is for the year ending 31 March 2025, and the last AGM was on 30 September 2025. Two charges (secured loans) are still open, with Hdfc Bank Limited among the lenders.

Pharma ••••••••
  • Location Plot No 69, 8-2-248/1/7/69 Nagarjuna Hills, Punjagutta, Hyderabad, Telangana - 500082
  • Website abiogenesisclinpharm.com
Legal NameAbiogenesis Clinpharm Private Limited
CIN / LLPINU74930TG2014PTC096506
Company No.096506
ClassificationPrivate Limited Indian Non-Government Company
Incorporation Date2014-11-21
Date of AGM2025-09-30
Date of Balance Sheet2025-03-31
Listing StatusUnlisted
ROC CodeRoc Hyderabad
PAN
LEI Number
Active ComplianceActive Compliant

Current Directors of Abiogenesis Clinpharm (3) Current board members from MCA filings, including designation and appointment details.

A
Director | Since 2019-07-26 | DIN: 08523909
P
Director | Since 2014-11-21 | DIN: 06989844
K
Additional Director | Since 2025-11-03 | DIN: 11365656

Financial Performance of Abiogenesis Clinpharm Bands and Low / Medium / High trend shape. Exact figures unlock with your report.

Estimated bands · FY 2020
Revenue ₹5–10 Cr ▲ 195.0%
P&L ₹50 Lakh–1 Cr ▲ 319.6%
EBITDA ₹50 Lakh–1 Cr ▲ 526.8%
Net worth ₹50 Lakh–1 Cr ▲ 163.0%

Exact figures and labelled charts require an active report plan.

Verified entity values are shown only after access is granted.

Charges of Abiogenesis Clinpharm Open and satisfied charges registered against the company with MCA.

Others : 3.00 cr
Hdfc Bank Limited : 1.30 cr
Open Charges: 2 Satisfied Charges: 0
Open -
Satisfied 0
LenderAmountStatus
Others
Creation Date: 26 Sep 2025
3.00 cr Open
Hdfc Bank Limited
Creation Date: 01 Aug 2025
1.30 cr Open

Business Activity Principal business activity and turnover mix from MCA filings.

Activity GroupDescriptionTurnover %
Professional, Scientific and TechnicalOther professional, scientific and technical activities100

Financial Ratios of Abiogenesis Clinpharm Profitability, leverage, and liquidity ratios from filed statements. Exact values unlock with your report.

6 years of ratios on record

Profitability, leverage and liquidity ratios require an active report plan.

Net profit margin Debt / Equity Current ratio ROE

Unlock exact ratio values and multi-year insights.

Verified entity values are shown only after access is granted.

Shareholding Pattern of Abiogenesis Clinpharm Ownership and contribution detail from filings. Full breakdown unlocks with your report.

4 shareholder categories on record

Ownership mix and contribution history require an active report plan.

Ownership mix Category breakdown Year-wise pattern Promoter holding

Unlock full ownership and contribution details.

Verified entity values are shown only after access is granted.

Employees and EPFO Compliance at Abiogenesis Clinpharm EPFO establishments, contributions, and headcount history. Full records unlock with your report.

1 establishment linked

Monthly headcount, contribution history, establishment records, and filing compliance require an active report plan.

Monthly headcount PF contributions ECR filing status Establishment history

Employee and EPFO history require an active report plan.

Verified entity values are shown only after access is granted.

GST Compliance of Abiogenesis Clinpharm GST registrations and filing status by state. Full compliance detail unlocks with your report.

State-wise registrations, return filing status, HSN and SAC details, and jurisdiction records require an active report plan.

GSTIN registrations State-wise filing status HSN and SAC details Tax jurisdiction records

GST registrations and filing compliance require an active report plan.

Verified entity values are shown only after access is granted.

MSME Payment Delays by Abiogenesis Clinpharm MSME supplier payment delays and filing history. Full amounts unlock with your report.

Amounts outstanding to micro and small suppliers, delay reasons, and MSME-1 filing history require an active report plan.

Outstanding amounts Delay periods and reasons MSME-1 filing history Vendor payment signals

MSME payment history requires an active report plan.

Verified entity values are shown only after access is granted.

MCA Filings & Documents of Abiogenesis Clinpharm Official MCA forms, returns, and filing index. Document access unlocks with your report.

Official forms, annual returns, financial statements, charge filings, and document dates require an active report plan.

Incorporation documents Annual returns and statements Charge filings Complete filing index

MCA filings and documents require an active report plan.

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Abiogenesis Clinpharm Common questions about this company from MCA and profile data. Some answers are limited until unlocked.
Who is the owner of Abiogenesis Clinpharm?
MCA does not publish an "owner" field. Abiogenesis Clinpharm is run by its directors, Abraham Chikku Joseph, Pawan Ishwarrao Bhusari and Kalpesh Kumar Prabhudas Saglani. The people who own the shares are listed in its annual return (form MGT-7), which can differ from the directors.
Who are the current board members and directors of Abiogenesis Clinpharm?
Abiogenesis Clinpharm has three current directors: Abraham Chikku Joseph (since July 2019), Pawan Ishwarrao Bhusari (since November 2014) and Kalpesh Kumar Prabhudas Saglani (since November 2025).
What is CIN of Abiogenesis Clinpharm?
The CIN of Abiogenesis Clinpharm is U74930TG2014PTC096506. Reading it left to right: U means it is not listed, 74930 is the industry code it registered under, TG is Telangana, 2014 is the year it was registered, PTC is the company type and 096506 is its registration number.
When was Abiogenesis Clinpharm incorporated?
Abiogenesis Clinpharm was incorporated on 21 November 2014 with ROC Hyderabad. That makes it about 11 years old.
What is the registered address of Abiogenesis Clinpharm?
The registered office on MCA records is Plot No 69, 8-2-248/1/7/69 Nagarjuna Hills, Punjagutta, Hyderabad, Telangana - 500082.
What is the current status of Abiogenesis Clinpharm?
MCA shows Abiogenesis Clinpharm as Active, and its last AGM on record was in September 2025.
What is the contact number or email for Abiogenesis Clinpharm?
You can post to its registered office at Plot No 69, 8-2-248/1/7/69 Nagarjuna Hills, Punjagutta, Hyderabad, Telangana - 500082 and use its website, https://abiogenesisclinpharm.com.
What industry or business activity is Abiogenesis Clinpharm associated with?
Its MCA filings list the main business as other professional, scientific and technical activities (100% of turnover).
What is paid-up capital and authorised share capital of Abiogenesis Clinpharm?
Both authorised and paid-up capital are ₹1.25 crore.
When did Abiogenesis Clinpharm last file accounts and hold an AGM?
The last AGM on record was on 30 September 2025, and the latest balance sheet is for the year ending 31 March 2025.
Where can I see charges and lenders for Abiogenesis Clinpharm?
Two charges against Abiogenesis Clinpharm are still open. Lenders named in the filings include Hdfc Bank Limited.
Have any directors left Abiogenesis Clinpharm?
Yes, one former director is on record. Snehal Bhusari (July 2019) left.
What is the turnover or revenue of Abiogenesis Clinpharm?
Based on filed financial statements, the revenue of Abiogenesis Clinpharm for FY 2020 was in the ₹5–10 Cr range. That is up 195.0% on the previous year. Exact year-wise revenue, profit and balance sheet figures are on the Financial tab.
What is the net worth of Abiogenesis Clinpharm?
For FY 2020, the net worth of Abiogenesis Clinpharm was in the ₹50 Lakh–1 Cr range.
How can I get the financial details of Abiogenesis Clinpharm?
The latest accounts on record are for FY 2020. The Financial tab has year-wise profit and loss, balance sheet and ratios, with exact figures after you sign in.
What is the official website of Abiogenesis Clinpharm?
The website on record for Abiogenesis Clinpharm is https://abiogenesisclinpharm.com.
Which company owns abiogenesisclinpharm.com?
abiogenesisclinpharm.com is the website listed for Abiogenesis Clinpharm Private Limited in its company records.
Abiogenesis Clinpharm - is it listed or unlisted?
Abiogenesis Clinpharm is unlisted, so its shares are not traded on a stock exchange. Its CIN starts with U for the same reason.
What is the ROC code of Abiogenesis Clinpharm?
Abiogenesis Clinpharm is registered with ROC Hyderabad.
What is the company classification of Abiogenesis Clinpharm?
MCA classifies Abiogenesis Clinpharm as: Private Limited Indian Non-Government Company.
Does Abiogenesis Clinpharm have GST registrations on file?
Yes, one active GST registration is linked to Abiogenesis Clinpharm.

Disclaimer: Data on this page is compiled from public sources as available in our system at the time of the last update and is for general information only. Scores are derived indicators, not credit ratings or advice - please verify from official sources and consult a professional before making any business or financial decision.